Donor-derived cell-free DNA as a biomarker of T cell mediated rejection in pediatric kidney transplant patients
Friday, April 22, 2022
7:15 PM – 7:30 PM US MT
Location: Convention Center: 708/710/712
CE: Enduring CME: 0.25
Publication Number: 595.5
Raja Dandamudi, Washington University in St. Louis School of Medicine, St. Louis, MO, United States; Stuart D. Federman, CareDx, Saint Louis, MO, United States; Robert N. Woodward, CareDx, South San Francisco, CA, United States; Shamik Dholakia, CareDx, San Francisco, CA, United States; Leslie Walther, Washington University in St. Louis, St. Louis, MO, United States; Vikas R. Dharnidharka, Washington University in St Louis, Creve Coeur, MO, United States
Presenting Author(s)
RD
Raja Dandamudi, MD
Assistant Professor Washington University in St. Louis School of Medicine St. Louis, Missouri, United States
Participants should be aware of the following financial/non-financial relationships:
Raja Dandamudi, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Stuart D. Federman, Pharm D., MBA: ● CareDx (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Robert N. Woodward, PhD: ● CareDx (Currently Ongoing) (Products/Services: Employment with an ineligible company, Ownership Interest including individual stocks, stock options, excluding diversified mutual funds).
Shamik Dholakia, MD, DPhil: ● CareDx (Currently Ongoing) (Products/Services: Employment with an ineligible company).
Leslie Walther, BSN: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Vikas R. Dharnidharka, MD, MPH: ● Atara Bio (Currently Ongoing) (Products/Services: Consultant). ● CareDx (Currently Ongoing) (Products/Services: Research Support including clinical trials & the principal or named investigator).
